Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 22, 2023

SELL
$155.98 - $172.65 $2.68 Million - $2.97 Million
-17,188 Reduced 40.69%
25,054 $251,000
Q4 2022

Jan 26, 2023

SELL
$102.55 - $135.33 $211,560 - $279,185
-2,063 Reduced 4.66%
42,242 $0
Q3 2022

Oct 28, 2022

SELL
$95.28 - $116.93 $4,573 - $5,612
-48 Reduced 0.11%
44,305 $4.72 Million
Q2 2022

Aug 02, 2022

BUY
$103.24 - $121.81 $529,517 - $624,763
5,129 Added 13.08%
44,353 $5.14 Million
Q1 2022

Apr 27, 2022

BUY
$93.1 - $112.54 $235,915 - $285,176
2,534 Added 6.91%
39,224 $4.36 Million
Q4 2021

Feb 18, 2022

SELL
$95.88 - $117.08 $192,239 - $234,745
-2,005 Reduced 5.18%
36,690 $4.11 Million
Q3 2021

Nov 22, 2021

SELL
$84.42 - $106.62 $6.13 Million - $7.74 Million
-72,584 Reduced 65.23%
38,695 $3.72 Million
Q2 2021

Aug 26, 2021

SELL
$67.66 - $84.76 $1.18 Million - $1.48 Million
-17,469 Reduced 13.57%
111,279 $9.32 Million
Q1 2021

Apr 28, 2021

BUY
$67.06 - $75.82 $218,012 - $246,490
3,251 Added 2.59%
128,748 $8.68 Million
Q4 2020

Jan 28, 2021

BUY
$63.89 - $73.8 $268,721 - $310,402
4,206 Added 3.47%
125,497 $8.77 Million
Q3 2020

Oct 30, 2020

SELL
$63.69 - $70.22 $231,322 - $255,039
-3,632 Reduced 2.91%
121,291 $8.42 Million
Q2 2020

Jul 31, 2020

BUY
$58.54 - $67.94 $1.04 Million - $1.21 Million
17,765 Added 16.58%
124,923 $8.18 Million
Q1 2020

May 01, 2020

SELL
$49.46 - $64.78 $270,991 - $354,929
-5,479 Reduced 4.86%
107,158 $6.45 Million
Q4 2019

Feb 07, 2020

BUY
$49.86 - $58.26 $277,670 - $324,449
5,569 Added 5.2%
112,637 $6.52 Million
Q3 2019

Oct 31, 2019

SELL
$47.54 - $53.43 $206,799 - $232,420
-4,350 Reduced 3.9%
107,068 $5.54 Million
Q2 2019

Aug 02, 2019

SELL
$46.79 - $52.47 $465,981 - $522,548
-9,959 Reduced 8.21%
111,418 $0
Q1 2019

May 02, 2019

SELL
$46.36 - $52.63 $5.18 Million - $5.88 Million
-111,666 Reduced 47.92%
121,377 $0
Q4 2018

Feb 06, 2019

BUY
$41.54 - $47.25 $50,886 - $57,881
1,225 Added 0.53%
233,043 $10.9 Million
Q3 2018

Nov 01, 2018

BUY
$46.76 - $51.24 $230,339 - $252,408
4,926 Added 2.17%
231,818 $9.91 Million
Q2 2018

Aug 01, 2018

BUY
$44.29 - $50.42 $3.45 Million - $3.93 Million
77,923 Added 52.31%
226,892 $11.4 Million
Q1 2018

May 01, 2018

SELL
$48.49 - $58.14 $1.75 Million - $2.1 Million
-36,136 Reduced 19.52%
148,969 $7.1 Million
Q4 2017

Feb 02, 2018

SELL
$47.53 - $53.73 $186,460 - $210,782
-3,923 Reduced 2.08%
185,105 $10.7 Million
Q3 2017

Nov 06, 2017

BUY
$41.15 - $49.22 $7.78 Million - $9.3 Million
189,028
189,028 $9.43 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.